News & Updates

Initiation of a glucagon-like peptide-1 (GLP-1) agonist at standard glycaemic control doses may result in modest weight loss through 72 weeks in patients with overweight or obesity and type 2 diabetes, suggest the results of a real-world study.

Almond consumption led to improvements in cardiometabolic, glycaemic, and insulin markers in Asian Indian adults with overweight and obesity, a study has shown.

Notable phenotypic differences are present in patients with pituitary stalk interruption syndrome (PSIS) who are overweight or obese, which indicate hypothalamic defects, reports a study.

Boys with sustained exposure to secondhand smoke are at increased risk of obesity, as reported in a study.

Reduced muscle strength (dynapenia) is associated with a higher risk of leg and ankle fractures in women with obesity, as shown in a study. Dynapenia also negates the protective effects of obesity on fractures of the wrist, arm, hip, spine, and other bones, thus increasing the risk of falls.

Children diagnosed with asthma between ages 5 and 7 years may have an increased risk of developing type 1 diabetes (T1D) and inflammatory bowel diseases (IBD; Crohn’s disease and ulcerative colitis), a Danish nationwide registry study suggests.

For individuals with obesity, weight loss surgery may prevent premature death and improve chances of having a longer life.